Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection

Journal of Clinical Investigation

Volumn 105, Issue 1, 2000, Pages 35-44

  Gao, Wei ^a   Topham, Peter S ^a,b   King, Jennifer A ^a   Smiley, Stephen T ^a   Csizmadia, Vilmos ^a   Lu, Bao ^c   Gerard, Craig J ^c   Hancock, Wayne W ^a,d  

^a MILLENNIUM PHARMACEUTICALS INC   (United States)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR 1; CYCLOSPORIN A; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ADHESION; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; GRAFT REJECTION; GRAFT SURVIVAL; HEART GRAFT; HELPER CELL; HISTOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; RECEPTOR DOWN REGULATION; RIBONUCLEASE PROTECTION ASSAY;

EID: 0033987396     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI8126     Document Type: Article

References (35)

1. Springer, T.A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the mulristep paradigm. Cell. 76:301-314.
2. Eitner, R, Cui, Y., Hudkins, K.L., and Alpers, C.E. 1998. Chemokine receptor (CXCR4) mRNA-expressing leukocytes are increased in human renal allograft rejection. Transplantation. 66:1551-1557.
3. Eitner, F., et al. 1998. Chemokine receptor (CCR5) expression in human kidneys and in the HIV infected macaque. Kidney Int. 54:1945-1954.
4. Neote, K., DiGregorio, D., Mak, J.Y., and Schall, T.J. 1993. Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell 72:415-425.
5. Gerard, C., et al. 1997. Targeted disruption of the beta-chemokine receptor CCR1 protects against pancreatitis-associated lung injury. J. Clin. Invest. 100:2022-2027.
6. Hancock, W.W., Buelow, R., Sayegh, M.H., and Turka, LA. 1998. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant andanti-apoptotic genes. Nat. Med. 4:1392-1396.
7. Gao, Z.H., et al. 1999. Adoptively transferable tolerance induced by CD45RB monoclonal antibody. J. Am. Soc. Nephrol. 10:374-381.
8. Mottram, P.L., Han, W.R., Purcell, L.J., McKenzie, I.F.C., and Hancock, W.W. 1995. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-g in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy. Transplantation. 59:559-565.
9. Breitschopf, H., and Suchanek, G. 1996. Detection of mRNA on paraffin embedded material of the central nervous system with DIG-labeled RNA probes. In Nonradioactive in situ hybridization application manual. Boehringer Mannheim Biochemicals. Vienna, Austria. 1-52.
10. Smiley, S T, Boyer, S N., Heeb, M J., Griffin, J.H., and Grusby, M.J. 1997. Protein S is indudble by interleukin 4 in T cells and inhibits lymphoid cell procoagulant activity. Proc. Natl. Acad. Sci. USA. 94:11484-11489.
11. Chomczynski, P., and Sacchi, N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal. Biochem. 162:156-159.
12. Post, T.W., et al. 1995. Molecular characterization of two murine eosinophil beta chemokine receptors. J. Immunol. 155:5299-5305.
13. Smith, J.D., Rose, M.L., Pomerance, A., Burke, M., and Yacoub, M.H. 1995. Reduction of cellular rejection and increase in longer-term survival after heart transplantation after HLA-DR matching. Lancet. 346:1318-1322.
14. Fahey, T.J., et al. 1992. Macrophage inflammatory protein 1 modulates macrophage function. J. Immunol. 148:2764-2769.
15. Berkman, N., et al. 1995. Inhibition of macrophage inflammatory protein-1 alpha expression by IL-10: differential sensitivities in human blood monocytes and alveolar macrophages. J. Immunol. 155:4412-4418.
16. Standiford, T.J., et al. 1993. Macrophage inflammatory protein-1 alpha from human blood monocytes and alveolar macrophages is inhibited by interleukin-4. Am. J. Respir. Cell Mol. Biol. 9:192-198.
17. Maltman, J., Pragnell, I.B., and Graham, G.J. 1996. Specificity and reciprocity in the interactions between TGF-beta and macrophage inflammatory protein-1 alpha. J. Immunol. 156:1566-1571.
18. Taub, D.D.,Turcovski-Corrales, S.M., Key, M.L., Longo, D.L., and Murphy, W.J. 1996. Chemokines and T lymphocyte activation. I. beta chemokines costimulate human T lymphocyte activation in vitro. J. Immunol. 156:2095-2103.
19. Tomura, M., et al. 1997. Suppression of allograft responses induced by interleukin-6, which selectively modulates interferon-gamma but not interleukin-2 production. Transplantation. 64:757-763.
20. Ring, G.H., et al. 1999. Interferon-gamma is necessary for initiating the acute rejection of major histocompatibility complex class II-disparate skin allografts. Transplantation. 67:1362-1365.
21. Foti, M., et al. 1999. Upon dendritic cell (DC) activation chemokines and chemokine receptor expression are rapidly regulated for recruitment and maintenance of DC at the inflammatory site. Int. Immunol. 11:979-986.
22. Larsen, C.P., et al. 1996. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature. 381:434-438.
23. Kirk, A. D., et al. 1999. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in non-human primates. Nat. Med. 5:686-693.
24. Zipfel, P.P., Bialonski, A., and Skerka, C. 1991. Induction of members of the IL-8/NAP-1 gene family in human lymphocytes-T is suppressed by Cyclosporin-A. Biochem. Biophys. Res. Commun. 181:179-183.
25. Mrowietz, U., Sticherling, M., Mielke, V., Schroder, J.M., and Christophers, E. 1991. Neutrophil-activating peptide 1/interleukin 8 mRNA expression and protein secretion by human monocytcs: effect of cyclosporin A. Cytokine. 3:322-326.
26. Losa Garcia, J.E., et al. 1998. Effect of cyclosporin A on inflammatory cytokine production by human alveolar macrophages. Respir. Med. 92:722-728.
27. Burnstine, M.A., Elner, S.G., and Elner, V.M. 1998. Orbital fibroblast chemokine modulation: effects of dexamethasone and cyclosporin A. Br. J. Opbthalmol. 82:318 322.
28. Sakamoto, H., et al. 1997. Immunosuppressive drugs inhibit the production of interleukin-6 and interleukin-8 in cultured cardiac myxoma cells. Res. Commun. Mol. Pathol. Pharmacol. 97:60-66.
29. Wang, J.D., et al. 1998. Lymphotactin: a key regulator of lymphocyte trafficking during acute graft rejection. Immunology. 95:56 61.
30. Khanna, A., Li, B.C., Stenzel, K.H., and Suthanthiran, M. 1994. Regulation of new DNA synthesis in mammalian cells by cyclosporine: demonstration of a transforminggrowth factor beta-dependent mechanism of inhibition of cell growth. Transplantation. 57:577 582.
31. Hancock, W.W., Kusaka, M., Mackenzie, H.S., and Tilney, N.L. 1999. Hypertension induces transplant arteriosclerosis in rat renal allografts via endothelin and chemokine receptor induction by vascular smooth muscle cells. Transplantation. 67:S574. (Abstr.)
32. Kennedy, L.J., and Weissman, I.L. 1971. Dual origin of intimai cells in cardiac-allograft arteriosclerosis. N. Engl. J. Med. 285:884-887.
33. Vischjager, M., Van Gulik, T.M., Van Marie, J., Pfaffendorf, M., and Jacobs, M.J. 1996. Function of cryopreserved arterial allografts under immunosuppressive protection with cyclosporine A.J. Vasc. Surg. 24:876-882.
34. Tilney, N.L. 1999. Chronic rejection and its risk factors. Transplant. Proc. 31:41S-44S.
35. Hancock, W.W. 1999. Molecular basis of chronic rejection. Curr. Opin. Organ Transplant. 4:3-10.